Laboratoire Mémoire et Cognition, Institut de Psychologie, Université Paris Descartes, France.
Compr Psychiatry. 2013 May;54(4):369-80. doi: 10.1016/j.comppsych.2012.10.005. Epub 2012 Nov 28.
The origins of poor insight in schizophrenia are still unclear. We contrasted the changes in clinical insight, basic cognitive processes, autobiographical memory and metacognition in 63 outpatients with schizophrenia pseudo-randomly assigned to one of three cognitive remediation groups: one targeting basic cognitive processes (RECOS), a second autobiographical memory (REMAu), and a third metacognitive deficits (MBCT). Three dimensions of insight (awareness of: mental illness, benefit of treatment, psychosocial consequences) improved after treatment, regardless of the group. In addition, the REMAu and MBCT showed an improvement on other dimensions of insight (symptomatic awareness and symptomatic attribution, respectively). Poor insight and its improvement after treatment were best predicted by a combination of basic cognitive, autobiographical and metacognitive measures. This study supports a multidimensional conception of insight and recommends the combination of remediation therapies to improve clinical insight in schizophrenia.
精神分裂症患者洞察力差的根源仍不清楚。我们将 63 名精神分裂症门诊患者进行了对照研究,这些患者被随机分配到三个认知矫正组中的一个:一个针对基本认知过程(RECOS),一个针对自传体记忆(REMAu),另一个针对元认知缺陷(MBCT)。无论分组如何,治疗后患者的洞察力的三个维度(对精神疾病、治疗益处和心理社会后果的认识)都有所提高。此外,REMAu 和 MBCT 分别在其他维度的洞察力(症状意识和症状归因)上有所提高。洞察力差及其治疗后的改善程度最好由基本认知、自传体记忆和元认知测量的组合来预测。本研究支持洞察力的多维概念,并建议联合矫正治疗以改善精神分裂症患者的临床洞察力。